Discovery of [Cis-3-({(5r)5-[(7-Fluoro-1,1-Dimethyl-2,3-Dihydro1Hinden-5-Yl)carbamoyl]-2-Methoxy-7,8-Dihydro-1,6-Naphthyridin-6(5H)yl}carbonyl)cyclobutyl]acetic Acid (TAK-828F) as a Potent, Selective, and Orally Available Novel Retinoic Acid Receptor-Related Orphan Receptor T Inverse Agonist
